WuXi Diagnostics
PrivateLast Round
Series B
Feb 23, 2021
Est. Valuation
$22.77M
Total Funding Raised
$154.55M
Company Overview
WuXi Diagnostics operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B round in February 2021.
WuXi Diagnostics is a healthcare company that provides an integrated clinical diagnostic platform offering testing solutions from research to clinical practice, including screening, early diagnosis, clinical decision support, and prognosis management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WuXi Diagnostics Comparables
Compare WuXi Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Guangzhou Huayin Health Technology Co., Ltd. | 78% | |
| Guangzhou Kingmed Diagnostics Group Co Ltd | 76% | |
| Dian Diagnostics Group | 73% |
For institutional investors. Book with your work email.
WuXi Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 23, 2021 | ||||
| Series A | Oct 18, 2019 | ||||
| Joint Venture | Jan 25, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
WuXi Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sunland Fund | Series B |
| Agricultural Bank of China International | Series B |
| Lake Bleu Capital | Series A |
| CCB International | Series B |
| CCBI Tech Venture | Series B |
| Shiyu Capital | Series B |
| Yunfeng Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors grew 588% MoM, from 99 to 681.
For institutional investors. Book with your work email.
WuXi Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about WuXi Diagnostics's valuation, stock price, and market status.
Is WuXi Diagnostics a public or private company?
WuXi Diagnostics is a private company.
What is the current stock price of WuXi Diagnostics?
WuXi Diagnostics is a private company, so its shares have no public market price. Caplight tracks WuXi Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is WuXi Diagnostics worth (valuation)?
WuXi Diagnostics's valuation is estimated at $22.8M based on funding round data.
Can I buy WuXi Diagnostics stock?
WuXi Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was WuXi Diagnostics's last funding round?
WuXi Diagnostics's most recent funding round was Series B on February 23, 2021.
Who are the main investors in WuXi Diagnostics?
Key investors in WuXi Diagnostics include Yunfeng Capital.
Will WuXi Diagnostics IPO soon?
No public IPO plans have been announced for WuXi Diagnostics.
How can I track WuXi Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in WuXi Diagnostics's shares on secondary markets.